Synergistic modulation of lymphocyte mitogenesis by carcinogenic xenobiotics.
D001151:Arsenic / Q000633:toxicity; D018053:Arsenites; D002273:Carcinogens / Q000494:pharmacology*; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects* / Q000528:radiation effects; D008934:Mitogens / Q000494:pharmacology*; D017670:Sodium Compounds; D013936:Thymidine / Q000378:metabolism; D014466:Ultraviolet Rays
D018053:Arsenites; D002273:Carcinogens; D008934:Mitogens; D017670:Sodium Compounds; C017947:sodium arsenite; D001151:Arsenic; D013936:Thymidine